Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.46 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.46 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.46 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.46 |
| ▸ | CAMK2B | Q13554 | 1/20 | 0.46 |
| ▸ | CAMK2G | Q13555 | 1/20 | 0.46 |
| ▸ | CAMK2D | Q13557 | 1/20 | 0.46 |
| ▸ | TAOK1 | Q7L7X3 | 1/20 | 0.46 |
| ▸ | PPARD | Q03181 | 1/20 | 0.44 |
| ▸ | LTA4H | P09960 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL677508 | 0.94 | CYP1A2 (0.50) | CYP1A2CYP2C9CYP2C19L3MBTL1MAPT | |
| SCHEMBL677289 | 0.93 | MAPT (0.51) | CYP1A2CYP2C9CYP2C19L3MBTL1MAPT | |
| SCHEMBL677597 | 0.93 | MAPT (0.51) | CYP1A2CYP2C9CYP2C19L3MBTL1MAPT | |
| SCHEMBL2924592 | 0.93 | MAPT (0.51) | CYP1A2CYP2C9CYP2C19L3MBTL1MAPT | |
| SCHEMBL17309906 | 0.93 | MAPT (0.51) | CYP1A2CYP2C9CYP2C19L3MBTL1MAPT | |
| SCHEMBL3200502 | 0.90 | L3MBTL1 (0.52) | CYP1A2CYP2C9CYP2C19L3MBTL1MAPT | |
| SCHEMBL59202 | 0.85 | CYP1A2 (0.53) | CYP1A2CYP2C9CYP2C19L3MBTL1MAPT | |
| SCHEMBL9689273 | 0.84 | L3MBTL1 (0.69) | CYP1A2CYP2C9CYP2C19L3MBTL1MAPT | |
| SCHEMBL676117 | 0.84 | CYP1A2 (0.47) | CYP1A2CYP2C9CYP2C19L3MBTL1MAPT | |
| SCHEMBL919038 | 0.82 | CYP1A2 (0.58) | CYP1A2CYP2C9CYP2C19L3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8937090-B2 | Parakeratosis inhibitor, pore-shrinking agent and external composition for skin | SHISEIDO COMPANY, LTD. (JP) | 2015-01-20 | — | — | US | disclosed |
| US-20120232111-A1 | Parakeratosis inhibitor, pore -shrinking agent and external compositon for skin | SHISEIDO COMPANY, LTD. (JP) | 2012-09-13 | — | — | US | disclosed |
| US-20120165409-A1 | WRINKLE-IMPROVING AGENT | SHISEIDO COMPANY, LTD. (JP) | 2012-06-28 | — | — | US | disclosed |
| US-20100035881-A1 | WRINKLE-IMPROVING AGENT | SHISEIDO COMPANY, LTD. (JP) | 2010-02-11 | — | — | US | disclosed |
| EP-1941861-A1 | WRINKLE-IMPROVING AGENT | Shiseido Company, Limited (JP) | 2008-07-09 | — | — | EP | disclosed |
| EP-1880711-A1 | PARAKERATOSIS INHIBITOR, PORE-SHRINKING AGENT AND EXTERNAL COMPOSITION FOR SKIN | Shiseido Company, Limited (JP) | 2008-01-23 | — | — | EP | disclosed |
| EP-1180765-B1 | Optical recording medium and porphycene compound | MITSUI CHEMICALS INC (JP) | 2005-04-06 | — | — | EP | disclosed |
| EP-1180765-A1 | Optical recording medium and porphycene compound | Mitsui Chemicals, Inc. (JP) | 2002-02-20 | — | — | EP | disclosed |
| US-6106999-A | SENSITIVITY TO GENERAL-PURPOSE VISIBLE LIGHT LASER, SO THAT HIGH-SPEED SCANNING EXPOSURE IS POSSIBLE BY LASER, AND EXTREMELY FINE HIGH RESOLUTION CAN BE OBTAINED; CAN BE USED FOR COATING OR PRINTING UNDER SAFELIGHT IRRADIATING CONDITIONS | MITSUI CHEMICALS (JP) | 2000-08-22 | — | — | US | disclosed |
| EP-0182157-B1 | ESTER DERIVATIVES OF ANTIBIOTIC L 17046 | GRUPPO LEPETIT S.p.A. (IT) | 1992-07-15 | — | — | EP | disclosed |
| US-4954483-A | BACTERICIDE, ANIMAL GROWTH PROMOTER | GRUPPO LEPETIT, S.P.A. (IT) | 1990-09-04 | — | — | US | disclosed |
| US-4914187-A | REACTING PROTECTED ANTIBIOTIC DERIVATIVE WITH ORGANIC HALIDE IN POLAR APROTIC SOLVENT | GRUPPO LEPETIT S.P.A (IT) | 1990-04-03 | — | — | US | disclosed |
| EP-0216775-B1 | CARBOXYLIC ACID ESTER DERIVATIVES OF DEGLUCOTEICOPLANIN | GRUPPO LEPETIT S.p.A. (IT) | 1989-05-03 | — | — | EP | disclosed |
| US-4661470-A | MICROBIOCIDES | GRUPPO LEPETIT S.P.A. (IT) | 1987-04-28 | — | — | US | disclosed |
| EP-0216775-A1 | CARBOXYLIC ACID ESTER DERIVATIVES OF DEGLUCOTEICOPLANIN. | LEPETIT SPA (IT) | 1987-04-08 | — | — | EP | disclosed |
| EP-0182157-A2 | Ester derivatives of antibiotic L 17046 | GRUPPO LEPETIT S.p.A. (IT) | 1986-05-28 | — | — | EP | disclosed |
| WO-1986000075-A1 | CARBOXYLIC ACID ESTER DERIVATIVES OF DEGLUCOTEICOPLANIN | GRUPPO LEPETIT S.P.A. (IT) | 1986-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100035881-A1 | WRINKLE-IMPROVING AGENT | AAAS, GLA, COL14A1 | CYP1A2 3833/4885CYP2C9 4495/4885CYP2C19 4474/4885 |
| US-20120232111-A1 | Parakeratosis inhibitor, pore -shrinking agent and external compositon for skin | CUTA, AAAS, NUP160 | CYP1A2 3980/4885CYP2C9 4638/4885CYP2C19 4494/4885 |
| US-20120165409-A1 | WRINKLE-IMPROVING AGENT | AAAS, GLA, COL14A1 | CYP1A2 3658/4885CYP2C9 4491/4885CYP2C19 4454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.